Business Wire

B2BROKER

16.11.2023 13:11:30 CET | Business Wire | Press release

Share
New B2BinPay v18 Introduces Unified Account System and Massive UI Revisions

B2BinPay, the leading crypto payment processor, has once again raised the bar with its latest v18 solution update. Building upon the success of their previous v17 release, the company has introduced significant advancements for their clients.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231116251906/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

B2BinPay v18 update introduces Account Merge - Unifying Merchant and Enterprise Models and streamlining onboarding and business management processes. The update also comes with a fully renewed front-end and enhanced regulatory compliance. (Graphic: Business Wire)

The new release boasts a unified account system, merging the Merchant and Enterprise models and making transaction management easier than ever before. Coupled with a revamped front end and reinforced regulatory compliance, B2BinPay continues to prioritise UX and security in this latest version.

Let’s explore these cutting-edge updates further.

Account Unification

This update brings about a new philosophy in how B2BinPay delivers its services by unifying the two business models (Merchant and Enterprise) into one user-friendly interface.

What exactly does this mean for B2BinPay's clients? It means a more streamlined and integrated experience, as the platform combines both the Merchant and Enterprise account functionality into one user-friendly interface, which means clients can now manage all their transactions within a single, unified system.

But the benefits don't stop there. The account unification also simplifies the registration process, making it easier for businesses to join the platform and use its services immediately. With equal conditions and a single, unified onboarding fee for all types of users, clients have the freedom to choose and transition between services as their business needs evolve without the worry of extra costs or complex administrative processes. With this new approach, businesses can focus on what truly matters – their growth.

Revamped Front-End and Richer Functionality

The v18 release features a redesigned front end that not only aligns with the sleek aesthetic of the B2Broker brand but also offers improved speed and security for users. The core features that have made B2BinPay a favourite among its users have been maintained, ensuring a smooth transition to the updated platform. Here are the sections that have been completely redesigned:

  • Wallets & Transfers

With a sleeker layout and optimised processes, users can quickly navigate through wallets & transfers sections without extra clicks and lengthy loadings. The update streamlines all financial operations, including payouts, bank withdrawals, and exchanges, providing a more seamless and time-saving experience for B2BinPay users.

  • Account Menu

The renewed Account Menu features an intuitive, more user-friendly and secure design. Users can now easily manage their preferences, control API permissions, and customise their profile from one central location. Additionally, the 2FA feature adds an extra layer of security to protect user accounts from unauthorised access.

The Payment Page has also been revamped to reflect the updated design philosophy of B2Broker. This ensures that all financial transactions are carried out in a protected environment.

  • Helpdesk

The updated Helpdesk provides a more streamlined and user-friendly experience for users. With a more defined schedule for multilingual support and new sticker notifications for incoming messages, users can now keep track of their inquiries more efficiently and receive timely responses from the B2BinPay team.

  • Rates Interface

The Rates interface has undergone several upgrades. One of the major changes is that Rates now have richer filtering and favourites options. Additionally, the section can now be accessed directly from the top-level menu instead of being hidden in Wallets.

  • Flexible Invoices

B2BinPay has removed the previous 7-day limit on merchant invoice expiration, allowing for customisation of timelines to fit each business's specific requirements better.

Complying with FATF Travel Rule

The v18 update brings enhanced Travel Rule compliance to the forefront. By partnering with Notabene, a leading provider of Travel Rule solutions, B2BinPay ensures strict adherence to the Financial Action Task Force (FATF) Travel Rules regulations.

The FATF Travel Rule requires VASPs, including B2BinPay, to collect and share personal information in cryptocurrency transactions to prevent money laundering and other unethical practices. New integration equipped B2BinPay with a robust system for detecting suspicious activities and eliminating fraud, providing clients with added peace of mind.

Final Remarks

In light of the growing popularity and acceptance of cryptocurrency, B2BinPay has established itself as a reliable and trustworthy solution in providing efficient crypto payment architecture for businesses. The launch of their v18 update showcases their commitment to constantly improving and expanding their services, staying ahead of market trends and regulatory standards.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231116251906/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release

REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit

Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press release

In myelofibrosis (MF), INCA033989 delivered rapid and durable clinical benefits including meaningful spleen volume reductions, symptom improvement and anemia responses, both as a monotherapy and in combination with ruxolitinibIn essential thrombocythemia (ET), 87% of patients achieved a hematologic response, including 70% complete responses; responses were rapid (median ~2 weeks to a durable complete hematologic response) and durable (median response duration of 23 weeks)Across MF and ET, INCA033989 consistently reduced mutant CALR (mutCALR) variant allele frequency (VAF) in most evaluable patients, with reductions correlating with clinical responses and supporting its potential for disease modificationFirst-in-class mutCALR-targeted antibody shows potential to modify disease biology in both MF and ETINCA033989 demonstrated a favorable and manageable safety profile with no dose-limiting toxicities, with most patients with MF and ET continuing treatment Incyte (Nasdaq:INCY) today announ

Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press release

- frontMIND study evaluating tafasitamab (Monjuvi®/Minjuvi®) in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL) selected for the prestigious Plenary Abstracts Session at EHA 2026 - Results showed tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) significantly prolonged progression-free survival (PFS), reducing risk of disease progression or death by 25% - Positive trends toward PFS benefit with Tafa-Len-R-CHOP were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypes - The frontMIND data support global regulatory applications for tafasitamab and lenalidomide in addition to R-CHOP for previously untreated DLBCL and HGBL Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified c

Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press release

Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til

IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press release

Venneman brings more than 30 years of digital transformation, AI, and enterprise technology experience as IQM prepares for its planned Nasdaq listing IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye